Zai Lab Announces Change to Virtual Extraordinary General Meeting of Shareholders to be Held on March 28, 2022 - SC Read more about Zai Lab Announces Change to Virtual Extraordinary General Meeting of Shareholders to be Held on March 28, 2022 - SC
Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting - SC Read more about Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting - SC
Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer-SC Read more about Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer-SC
Zai Lab Statement on SEC Provisional Listing Matter - SC Read more about Zai Lab Statement on SEC Provisional Listing Matter - SC
Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021 - SC Read more about Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021 - SC
Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China - SC Read more about Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China - SC
Zai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2022 - SC Read more about Zai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2022 - SC
Zai Lab Announces Upcoming Presentation at February Investor Conference - SC Read more about Zai Lab Announces Upcoming Presentation at February Investor Conference - SC
再鼎医药宣布肿瘤电场治疗用于胰腺癌的3期关键性临床研究PANOVA-3在大中华区完成首例患者入组 Read more about 再鼎医药宣布肿瘤电场治疗用于胰腺癌的3期关键性临床研究PANOVA-3在大中华区完成首例患者入组